Down's syndrome screening with nuchal translucency

被引：17

作者：

Hackshaw, AK

Wald, NJ

Haddow, JE

机构：

[1] ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,WOLFSON INST PREVENT MED,LONDON EC1M 6BQ,ENGLAND

[2] FDN BLOOD RES,SCARBOROUGH,ME 04074

来源：

LANCET | 1996年 / 348卷 / 9043期

关键词：

D O I：

10.1016/S0140-6736(05)65871-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1740 / 1740

页数：1

共 6 条

[1]

BEWLEY S, 1995, BRIT J OBSTET GYNAEC, V102, P386, DOI 10.1111/j.1471-0528.1995.tb11290.x

[2] Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness [J].

Hyett, JA ;

Sebire, NJ ;

Snijders, RJM ;

Nicolaides, KH .

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1996, 7 (02) :101-103

[3] SELECTIVE MISCARRIAGE OF DOWNS-SYNDROME FETUSES IN WOMEN AGED 35 YEARS AND OLDER [J].

MACINTOSH, MCM ;

WALD, NJ ;

CHARD, T ;

HANSEN, J ;

MIKKELSEN, M ;

THERKELSEN, AJ ;

PETERSEN, GB ;

LUNDSTEEN, C .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (10) :798-801

[4] Down's syndrome screening in the UK [J].

Nicolaides, KH ;

Sebire, NJ ;

Snijders, RJM ;

Johnson, S .

LANCET, 1996, 347 (9005) :906-907

[5]

Wald NJ, 1996, PRENATAL DIAG, V16, P143, DOI 10.1002/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO

[6]

2-F

← 1 →